140 related articles for article (PubMed ID: 37263806)
21. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
22. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.
Smith JD; Banner NR; Hamour IM; Ozawa M; Goh A; Robinson D; Terasaki PI; Rose ML
Am J Transplant; 2011 Feb; 11(2):312-9. PubMed ID: 21219570
[TBL] [Abstract][Full Text] [Related]
23. De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes.
Brooks AM; Carter V; Liew A; Marshall H; Aldibbiat A; Sheerin NS; Manas DM; White SA; Shaw JA
Am J Transplant; 2015 Dec; 15(12):3239-46. PubMed ID: 26227015
[TBL] [Abstract][Full Text] [Related]
24. Human Leukocyte Antigen Compatibility and De Novo Donor-Specific Antibodies in Long-term Renal Transplant Patients With Stable Graft Function.
Kasimatis E; Fylaktou A; Karampatakis T; Schoina M; Zarras C; Anastasiou A; Papachristou M; Boukla A; Daoudaki M; Fouzas I; Papagianni A
Transplant Proc; 2019 Mar; 51(2):413-415. PubMed ID: 30879554
[TBL] [Abstract][Full Text] [Related]
25. The impact of pre-transplant allosensitization on outcomes after lung transplantation.
Bosanquet JP; Witt CA; Bemiss BC; Byers DE; Yusen RD; Patterson AG; Kreisel D; Mohanakumar T; Trulock EP; Hachem RR
J Heart Lung Transplant; 2015 Nov; 34(11):1415-22. PubMed ID: 26169666
[TBL] [Abstract][Full Text] [Related]
26. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.
Hachem RR; Kamoun M; Budev MM; Askar M; Ahya VN; Lee JC; Levine DJ; Pollack MS; Dhillon GS; Weill D; Schechtman KB; Leard LE; Golden JA; Baxter-Lowe L; Mohanakumar T; Tyan DB; Yusen RD
Am J Transplant; 2018 Sep; 18(9):2285-2294. PubMed ID: 29687961
[TBL] [Abstract][Full Text] [Related]
28. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
29. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation.
Muro M; Legaz I
World J Gastroenterol; 2023 Feb; 29(5):766-772. PubMed ID: 36816626
[TBL] [Abstract][Full Text] [Related]
30. Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.
Verleden SE; Vanaudenaerde BM; Emonds MP; Van Raemdonck DE; Neyrinck AP; Verleden GM; Vos R
Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29146602
[TBL] [Abstract][Full Text] [Related]
31. De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure.
Mittal S; Page SL; Friend PJ; Sharples EJ; Fuggle SV
Am J Transplant; 2014 Jul; 14(7):1664-71. PubMed ID: 24866735
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation.
Lobashevsky A; Goggins W; Rosner K; Taber T
Transpl Immunol; 2017 Aug; 43-44():42-48. PubMed ID: 28629951
[TBL] [Abstract][Full Text] [Related]
33. De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study.
Kovandova B; Slavcev A; Honsova E; Erhartova D; Skibova J; Viklicky O; Trunecka P
Transpl Int; 2020 Dec; 33(12):1799-1806. PubMed ID: 33020979
[TBL] [Abstract][Full Text] [Related]
34. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
35. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M
Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of two methods to detect donor-specific anti-HLA antibodies after kidney transplant.
Gil BC; Kulzer ASS; de Moraes P; Toresan R; da Rosa Vicari A; Dos Santos Fagundes I; Merzoni J; Ewald GM; Cardone JM; Silva FG; Manfro RC; Jobim LF
Transpl Immunol; 2018 Aug; 49():7-11. PubMed ID: 29577967
[TBL] [Abstract][Full Text] [Related]
37. Effect of C1q-binding donor-specific anti-HLA antibodies on the clinical outcomes of patients after renal transplantation: A systematic review and meta-analysis.
Kang ZY; Liu C; Liu W; Li DH
Transpl Immunol; 2022 Jun; 72():101566. PubMed ID: 35257893
[TBL] [Abstract][Full Text] [Related]
38. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
[TBL] [Abstract][Full Text] [Related]
39. Lung intragraft donor-specific antibodies as a risk factor for graft loss.
Visentin J; Chartier A; Massara L; Linares G; Guidicelli G; Blanchard E; Parrens M; Begueret H; Dromer C; Taupin JL
J Heart Lung Transplant; 2016 Dec; 35(12):1418-1426. PubMed ID: 27450460
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation.
Jung HY; Kim SH; Seo MY; Cho SY; Yang Y; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
J Korean Med Sci; 2018 Aug; 33(34):e217. PubMed ID: 30127706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]